Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inhaled Interferon Gamma-1b in Pulmonary MAC Infection
NCT00043355Phase 2Terminated
- Sponsor
- InterMune
- Start
- Dec 2000
- Modality
- Cytokines & Interferons
01
Overview
Phase 2, randomised, double-blind trial in pulmonary Mycobacterium avium complex infection comparing Interferon gamma-1b with Placebo (2 arms). Primary endpoint: Sustained Culture Conversion at 52 weeks. Started Dec 2000; status: terminated.
02
Drugs
interferon gamma-1b
03
Conditions
pulmonary Mycobacterium avium complex infection
Beyond the preview
Go deeper on NCT00043355.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00043355.